SANUWAVE Health Inc (SNWV)
0.0239
0.00 (0.00%)
USD |
OTCM |
Apr 18, 09:46
SANUWAVE Health Free Cash Flow (Quarterly): -1.116M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.116M |
| September 30, 2023 | -2.038M |
| June 30, 2023 | -0.995M |
| March 31, 2023 | -0.389M |
| December 31, 2022 | -3.993M |
| September 30, 2022 | -7.975M |
| June 30, 2022 | -2.069M |
| March 31, 2022 | -3.132M |
| December 31, 2021 | 0.009M |
| September 30, 2021 | -1.421M |
| June 30, 2021 | -2.081M |
| March 31, 2021 | -3.445M |
| December 31, 2020 | -2.952M |
| September 30, 2020 | -4.192M |
| June 30, 2020 | -2.976M |
| March 31, 2020 | -2.651M |
| December 31, 2019 | -1.751M |
| September 30, 2019 | -1.301M |
| June 30, 2019 | -2.105M |
| March 31, 2019 | -1.308M |
| December 31, 2018 | -1.360M |
| September 30, 2018 | -0.6919M |
| June 30, 2018 | 0.2445M |
| March 31, 2018 | -1.856M |
| December 31, 2017 | -0.5841M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.3723M |
| June 30, 2017 | -0.4576M |
| March 31, 2017 | -0.1149M |
| December 31, 2016 | -0.493M |
| September 30, 2016 | -0.9857M |
| June 30, 2016 | -0.7196M |
| March 31, 2016 | -1.012M |
| December 31, 2015 | -0.4657M |
| September 30, 2015 | -1.090M |
| June 30, 2015 | -0.8377M |
| March 31, 2015 | -1.080M |
| December 31, 2014 | -1.136M |
| September 30, 2014 | -1.454M |
| June 30, 2014 | -1.974M |
| March 31, 2014 | -2.123M |
| December 31, 2013 | -0.5493M |
| September 30, 2013 | -1.391M |
| June 30, 2013 | -0.94M |
| March 31, 2013 | -1.044M |
| December 31, 2012 | -0.7438M |
| September 30, 2012 | -1.043M |
| June 30, 2012 | -1.014M |
| March 31, 2012 | -1.491M |
| December 31, 2011 | -1.843M |
| September 30, 2011 | -2.006M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-7.975M
Minimum
Sep 2022
0.009M
Maximum
Dec 2021
-2.451M
Average
-2.081M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -9.956M |
| Perspective Therapeutics Inc | -9.097M |
| Protalix BioTherapeutics Inc | 3.345M |
| Electromed Inc | 3.384M |
| Armata Pharmaceuticals Inc | -10.51M |